We provide cutting-edge, evidence-based treatments—including Spravato® (esketamine), Transcranial Magnetic Stimulation (TMS), and medically supervised IV Ketamine Therapy—for individuals battling treatment-resistant depression, severe anxiety, PTSD, OCD, and complex mood disorders. Deploy repeatable clinic-opening playbooks covering clinical staffing (nurses, psychiatric technicians, site managers), specialized licensing, local DEA registrations, IT infrastructure, and ramp-up targets to achieve on-time, budget-conscious clinic launches.